Skip to main content

Table 4 Results of the SureX HPV test and Venus HPV test by histopathological category

From: Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening

 

Total (%)

SureX HPV

Venus HPV

P value

Positive (%)

Negative (%)

Positive (%)

Negative (%)

Total

290 (100%)

227 (78.3)

63 (21.7)

227 (78.3)

63 (21.7)

1.00

Histological category

      

Normal

33 (11.4)

11 (33.3)

22 (66.7)

12 (36.4)

21 (63.6)

0.796

CIN1

56 (19.3)

28 (50.0)

28 (50.0)

30 (53.6)

26 (46.4)

0.705

CIN2

28 (9.7)

25 (89.3)

3 (10.7)

25 (89.3)

3 (10.7)

1.00

CIN3

35 (12.1)

34 (97.1)

1 (2.9)

30 (85.7)

5 (14.3)

0.088

CAa

138 (47.6)

130 (94.2)

8 (5.8)

130 (94.2)

8 (5.8)

1.00

  1. aCA includes adenocarcinoma in situ (ACIS), squamous cell carcinoma (SCC), adenocarcinoma (AC) and adenosquamous carcinoma (ASC)